Evidence map›Paper›PMID 9528830›Full record

ArticleBritish journal of cancer1998

Syndecan-1 is up-regulated in ras-transformed intestinal epithelial cells.

Z M Wong, B Choo, M Li, D J Carey, D F Cano-Gauci, R N Buick

Open access · bronzeAbstract read
In one paragraph

Article in British journal of cancer, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Z M WongOntario Cancer Institute and Department of Medical Biophysics, University of Toronto, Canada.
B Choo
M Li
D J Carey
D F Cano-Gauci
R N Buick
Cancer Institute (WIA) · INGeisinger Medical Center · USOntario Institute for Cancer Research · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The syndecans, a family of cell-surface heparan sulphate proteoglycans, have been proposed to mediate cellular interactions with extracellular effector molecules, such as growth factors and components of the extracellular matrix, during critical phases of development. Transcripts of all four syndecans are expressed at varying levels in the developing rat intestine and in a series of immature rat intestinal epithelial cell lines. In addition, we report the novel finding that, in the intestinal epithelial cell lines, expression of syndecan-1 transcript is up-regulated by transformation with activated H-ras. This is in contrast to other cell lines in which ras transformation is associated with a decrease in syndecan-1 levels. The observed increase in the syndecan-1 occurs as a result of increased transcription and can be correlated with the degree of transformation of the IEC-18 cells. Transformation is also associated with a decrease in apparent molecular weight and increased shedding of the proteoglycan into the culture medium. Increased shedding of syndecan-1 into the culture medium after transformation with H-ras may contribute to the disruption of proteoglycan interactions with the extracellular matrix, leading to alterations in cell adhesion and organization.

Indexed as

Genes, rasTranscription, GeneticAgingAnimalsAnimals, NewbornCell Line, TransformedCulture Media, ConditionedEmbryonic and Fetal DevelopmentGene Expression Regulation, DevelopmentalIntestinal MucosaMembrane GlycoproteinsProteoglycansRatsSyndecan-1Syndecan-2Syndecan-3Culture Media, ConditionedMembrane GlycoproteinsProteoglycansSdc1 protein, ratSdc2 protein, ratSdc3 protein, ratSdc4 protein, ratSyndecan-1Syndecan-2Syndecan-3Syndecan-4SyndecansTubulin

Identifiers

PMID9528830
PMCPMC2150088
OpenAlexW2049361121

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.